The global Livestock Vaccine Market is projected to grow at a CAGR of 5.8% during the forecast period 2022-2030.

Livestock Vaccine Market Overview:

The surge in livestock vaccine diseases has placed a considerable burden on the economies and agriculture of many countries. The use of livestock vaccines helps prevent many diseases in animals and the spread of these diseases to humans. Livestock vaccines are usually available in attenuated or inactivated forms and have been used successfully to prevent disease in both animals and humans. Potential benefits of livestock vaccines include improved animal welfare and public health.

Many clinical studies are using new vaccine technologies such as labeled vaccines, lysates, isolated proteins or peptides, and nucleic acid approaches to develop vaccines against various livestock diseases. Moreover, the global livestock vaccines market is paving the way for many important mergers and acquisitions. For example, in 2016, Elanco U.S., Inc., a subsidiary of Eli Lilly and Company, acquired the U.S. portfolio of canine, feline and rabies animal vaccines from Boehringer Ingelheim Veterinary, one of the major players in animal health.

Livestock Vaccine market size estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Livestock Vaccine market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and other global crisis.

The global Livestock Vaccine market is the professional and accurate study of various business perspectives such as major key players, key geographies, divers, restraints, opportunities, and challenges. This global research report has been aggregated on the basis of various market segments and sub-segments associated with the global market.

Industry News

• In March 2018, Zoetis introduced Fostera Gold PCV MH, which is US pork industry’s first vaccine to include two genotypes of porcine circovirus type 2 (PCV2) — 2a and 2b.
• In January 2019, Boehringer Ingelheim, announced that swine vaccine Ingelvac PRRS MLV, produced by its veterinary vaccine manufacturing plant in the China Medical City in Taizhou, Jiangsu Province, can be officially supplied to the China market.

Top Key Players include in the Livestock Vaccine Market are
GE Healthcare, Ceva Animal Health, Heska Corporation, Elanco/Eli Lilly, Bayer, Merck, Merial/Sanofi, Boehringer Ingelheim, and others.

The Livestock Vaccine market research report is categorized based on type, applications and region.

On the Basis of Type:

• Killed-type
• Live-type

On the Basis of Application:

• Cattle Sheep

On the Basis of Region:

Geographically, the global Livestock Vaccine market has been analyzed in various regions such as North America, Latin America, Middle East, Asia-Pacific, Africa, Europe, and India. The global Livestock Vaccine region is dominating this market in the upcoming future.

North America dominated the livestock vaccines market followed by Europe. The livestock vaccines market in North America is expected to expand over the forecast year owing to awareness about preventing animal-to-human transmission of diseases, higher demand for meat, and investments in research and development of animal vaccines. Asia Pacific is expected to grow at a significant CAGR over the forecast period owing to rising prevalence of livestock diseases such as foot-and-mouth disease (FMD) and highly pathogenic avian influenza (HPAI). Additionally, increasing incidence of zoonotic diseases and initiatives by government organizations and animal societies to provide livestock vaccines are expected to drive the growth of the livestock vaccines market in Asia Pacific. The livestock vaccines market in Middle East Africa and Latin America is in its infancy; however, it is expected to grow at a moderate CAGR during the forecast period.

Further the regions are divided into countries as follows

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Livestock Vaccine Market report scope

 The major key questions addressed through this innovative research report:

What are the major challenges in front of the global Livestock Vaccine market?

Who are the key vendors of the global Livestock Vaccine market?

What are the leading key industries of the global Livestock Vaccine market?

Which factors are responsible for driving the global Livestock Vaccine market?

What are the key outcomes of SWOT and Porter’s five analysis?

What are the major key strategies for enhancing global opportunities?

What are the different effective sales patterns?

What will be the global market size in the forecast period?

Any special requirements about this report, please let us know and we can provide custom report.